News

Skills and TrainingNew survey shows UK cell and gene therapy industry expects workforce to return to growth, following a challenging period of headcount reductions
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Budding UK innovation agency gains cash — and cloutBudding UK innovation agency gains cash — and clout£86 million funding announced for new medicine and technology£86 million funding announced for new medicine and technologyRegulatory news - June 2017Regulatory news - June 2017Designing a cell and gene therapy GMP cleanroomDesigning a cell and gene therapy GMP cleanroomPress release: Cell Medica acquisition of WT1 T-cell therapyPress release: Cell Medica acquisition of WT1 T-cell therapyConstructing the Cell and Gene Therapy Catapult manufacturing centreConstructing the Cell and Gene Therapy Catapult manufacturing centrePress release: Cell and Gene Therapy Catapult Licenses Cell Culture Data to Ajinomoto Co., Inc.Press release: Cell and Gene Therapy Catapult Licenses Cell Culture Data to Ajinomoto Co., Inc.Regulatory news - May 2017Regulatory news - May 2017Gene-modified T-cells: Going into battleGene-modified T-cells: Going into battleHighlights from ISCT 2017Highlights from ISCT 2017Cynata Therapeutics announce first patient treated in Phase I clinical trialCynata Therapeutics announce first patient treated in Phase I clinical trialStem cell therapies: can anything stop them now?Stem cell therapies: can anything stop them now?